Covid19
Pfizer, Mylan say COVID-19 delays will postpone their Viatris merger | Fierce Pharma
Now, thanks to COVID-19 delays, a generics megamerger between Pfizer's Upjohn unit and Mylan has been postponed until the back half of the year.
Now, thanks to COVID-19 delays, a generics megamerger between Pfizer's Upjohn unit and Mylan has been postponed until the back half of the year.
